This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What Awaits SBA Communications (SBAC) This Earnings Season?
by Zacks Equity Research
SBA Communications (SBAC) is likely to report higher y-o-y revenues in the first quarter, in both the operating segments, on the back of strong domestic and international site leasing activity.
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Logitech International and Molina Healthcare
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Logitech International and Molina Healthcare
Can Juniper (JNPR) Keep Earnings Beat Streak Alive in Q1?
by Zacks Equity Research
Juniper (JNPR) is likely to report lower y-o-y revenues in the first quarter due to challenges within the cloud vertical and risks related to the partial U.S. federal government shutdown.
Sony (SNE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Sony (SNE) is likely to report lower-than-expected sales in Financial Services, Semiconductors, Mobile Communications, and Imaging Products & Solutions segment in the fiscal fourth quarter.
Is a Beat Likely for Universal Health (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q1 is likely to gain traction from higher admissions as well as licensed beds. However, the same might be partially offset by escalating costs.
Centene's (CNC) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Centene's (CNC) first-quarter earnings top on solid revenue growth.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Bet on These 4 Liquid Stocks for a Successful Portfolio
by Zacks Equity Research
Four top-ranked liquid stocks that can make up a winning portfolio for investors.
Is a Beat in the Cards for Anthem's (ANTM) Q1 Earnings?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings are likely to benefit from an impressive operating performance and robust revenues, driven by its strong businesses.
Is a Beat in the Cards for Centene's (CNC) Q1 Earnings?
by Zacks Equity Research
Centene's (CNC) Q1 earnings are likely to gain from its solid Government and Medicaid businesses.
Zacks.com featured highlights include: Columbia Sportswear, Molina Healthcare, Acacia and Intuit
by Zacks Equity Research
Zacks.com featured highlights include: Columbia Sportswear, Molina Healthcare, Acacia and Intuit
WellCare Unit Inks Deal to Serve Medicaid Liver Patients
by Zacks Equity Research
WellCare's (WCG) unit inks a value-based deal to introduce the Hepatitis C Center of Excellence program for check-up and treatment of Medicaid members.
4 Top Stocks Thriving With Beat Potential This Earnings Season
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.
New Strong Buy Stocks for April 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Why the Earnings Surprise Streak Could Continue for Molina (MOH)
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UnitedHealth's (UNH) Unit to Upgrade Care Bundles Program
by Zacks Equity Research
UnitedHealth's (UNH) arm to offer better care with its enhanced UnitedHealthcare Care Bundles Program.
Centene on Track With Inorganic Strategies to Aid Growth
by Zacks Equity Research
A number of successful acquisitions over the years should aid Centene's (CNC) overall growth.
Why Investing in Centene Makes Sense for Portfolio Boost
by Zacks Equity Research
Centene (CNC) holds great potential for investment on the back of its growing revenue reserve and a solid inorganic growth story.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
5 Stocks to Prepare for a Global Economic Slowdown
by Swarup Gupta
In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant.
Centene Vs. Anthem: Which Stock is Better Ahead of Earnings?
by Zacks Equity Research
Centene and Anthem, two dominant players in the health insurance space, are set to gain in an expanding industry. We will see here which one is better placed ahead of earnings.
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $145.28, marking a +0.14% move from the previous day.
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.